Tom Burt

Tom Burt

Director/Board Member bij Synthace Ltd.

45 jaar
Finance
Consumer Services
Health Technology

Profiel

Thomas Henry Burt is currently a Director at Synthace Ltd., a Partner at Sofinnova Partners SAS, and a Member of the Association of Engineering Doctorates.
He previously worked as an Investment Director at Ares Life Sciences LP, an Investment Director at Novo Holdings Ltd., an Associate at Piper Sandler Ltd., and an Associate at Novo Principal Investments.
He also served as a Non-Executive Director at Redx Pharma Plc from 2020 to 2023 and as an Assistant Director at Peel Hunt LLP from 2015 to 2017.
Burt holds a graduate degree from the University of Birmingham and undergraduate and doctorate degrees from University College London.

Actieve functies van Tom Burt

BedrijvenFunctieBegin
Private Equity Investor 01-06-2017
Director/Board Member 12-11-2021
Association of Engineering Doctorates Corporate Officer/Principal -
Alle actieve functies van Tom Burt

Eerdere bekende functies van Tom Burt

BedrijvenFunctieEinde
REDX PHARMA PLC Director/Board Member 01-09-2023
Analyst-Equity 28-04-2017
Private Equity Analyst 31-01-2013
Chief Investment Officer -
Chief Investment Officer -
Ervaring van Tom Burt in detail bekijken

Opleiding van Tom Burt

University of Birmingham Graduate Degree
University College London Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Tom Burt in detail bekijken

Connecties

83

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
REDX PHARMA PLC

Health Technology

Bedrijven in privébezit8

Finance

Finance

Finance

Finance

Finance

Finance

Technology Services

Association of Engineering Doctorates

Zie bedrijfsconnecties